For the first time, Idifarma has participated in CPhI North America (24-26 April, Philadelphia, PA, USA).
After the mutual recognition agreement for GMP inspections FDA-EMA announced in November 2017, Idifarma participated in CPhI North America in order to learn more about the American market, and offer its specialised contract development and manufacturing services. In addition, we have introduced our GMP Spray Drying services for highly potent drugs, with a very positive response from many participating companies.
Our participation for the first time in a pharmaceutical event in the US is an important milestone for Idifarma, and allowed us to establish contact with several American companies which will hopefully turn into collaboration opportunities in the coming future.
Our thanks to all companies interested in knowing more about Idifarma.